IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3.

MLA

Ma, Min, et al. “IL-17 Inhibits the Accumulation of Myeloid-Derived Suppressor Cells in Breast Cancer via Activating STAT3.” International Immunopharmacology, vol. 59, June 2018, pp. 148–56. EBSCOhost, https://doi.org/10.1016/j.intimp.2018.04.013.

APA

Ma, M., Huang, W., & Kong, D. (2018). IL-17 inhibits the accumulation of myeloid-derived suppressor cells in breast cancer via activating STAT3. International Immunopharmacology, 59, 148–156. https://doi.org/10.1016/j.intimp.2018.04.013

Chicago

Ma, Min, Wei Huang, and Dehua Kong. 2018. “IL-17 Inhibits the Accumulation of Myeloid-Derived Suppressor Cells in Breast Cancer via Activating STAT3.” International Immunopharmacology 59 (June): 148–56. doi:10.1016/j.intimp.2018.04.013.